Related Experiment Video
Updated: Jan 23, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Nephrotic syndrome without kidney injury revealing intravascular large B cell lymphoma
Lucie Pothen1, Selda Aydin2, Alessandra Camboni2
1Service de Médecine interne et Maladies Infectieuses, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
Insights
This case study details a woman with fever of unknown origin who developed nephrotic syndrome and pulmonary infiltrates. Intracapillary glomerular invasion by intravascular large B cell lymphoma was diagnosed and successfully treated with R-CHOP and stem cell transplant.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Intravascular large B cell lymphoma (ILBCL) is a rare non-Hodgkin lymphoma.
- ILBCL can present with diverse clinical manifestations, including renal involvement.
Observation:
- A 64-year-old woman presented with fever of unknown origin.
- During hospitalization, she developed nephrotic syndrome and pulmonary infiltrates.
- Renal biopsy revealed intracapillary glomerular invasion by ILBCL.
Findings:
- The patient received treatment with rituximab, cyclophosphamide, doxorubicine, vincristine, and prednisone (R-CHOP) chemotherapy.
- Autologous stem cell transplant was performed following chemotherapy.
- Clinical and biological parameters improved significantly after treatment.
Implications:
- This case highlights the importance of considering ILBCL in the differential diagnosis of nephrotic syndrome with pulmonary involvement.
- Successful treatment of renal ILBCL with R-CHOP and stem cell transplant is demonstrated.
- Early diagnosis and aggressive treatment can lead to favorable outcomes in rare lymphoma presentations.
Abstract:
We describe the case of a 64-year-old woman admitted for fever of unknown origin, who developed nephrotic syndrome during hospitalisation and pulmonary infiltrates. Renal biopsy disclosed intracapillary glomerular invasion by intravascular large B cell lymphoma. Clinical and biological evolution was favourable after rituximab, cyclophosphamide, doxorubicine, vincristine and prednisone (R-CHOP) treatment and autologous stem cell transplant. Two years after diagnosis the patient was considered in remission.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care

